Technical Analysis for ISR - IsoRay, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| See historical ISR trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | 0.47% | |
| Calm After Storm | Range Contraction | 0.47% | |
| Upper Bollinger Band Walk | Strength | 0.47% | |
| Up 3 Days in a Row | Strength | 0.47% | |
| Upper Bollinger Band Touch | Strength | 0.47% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2019
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
IsoRay, Inc. engages in the development, manufacture, and sale of isotope-based medical products and devices for the treatment of cancer and other malignant diseases primarily in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds that are used for the treatment of prostate cancer; ocular melanoma; head, neck, and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancers. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer. IsoRay, Inc. is based in Richland, Washington.
Medicine Health Cancer Treatment Of Cancer Oncology Radiation Prostate Cancer Breast Cancer Medical Physics Radiation Therapy Pancreatic Cancer Colorectal Cancer Brain Cancer Treatment Of Prostate Cancer Esophageal Cancer Balloon Catheter Brachytherapy Liver Cancer Ocular Melanoma Pancreatic Cancers
Medicine Health Cancer Treatment Of Cancer Oncology Radiation Prostate Cancer Breast Cancer Medical Physics Radiation Therapy Pancreatic Cancer Colorectal Cancer Brain Cancer Treatment Of Prostate Cancer Esophageal Cancer Balloon Catheter Brachytherapy Liver Cancer Ocular Melanoma Pancreatic Cancers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ISR news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 1.22 |
| 52 Week Low | 0.269 |
| Average Volume | 148,015 |
| 200-Day Moving Average | 0.4348 |
| 50-Day Moving Average | 0.405 |
| 20-Day Moving Average | 0.4309 |
| 10-Day Moving Average | 0.445 |
| Average True Range | 0.0302 |
| ADX | 18.63 |
| +DI | 19.4069 |
| -DI | 8.1613 |
| Chandelier Exit (Long, 3 ATRs ) | 0.4044 |
| Chandelier Exit (Short, 3 ATRs ) | 0.4806 |
| Upper Bollinger Band | 0.4713 |
| Lower Bollinger Band | 0.3905 |
| Percent B (%b) | 0.95 |
| BandWidth | 18.751451 |
| MACD Line | 0.0153 |
| MACD Signal Line | 0.0123 |
| MACD Histogram | 0.0031 |
| Fundamentals | Value |
|---|---|
| Market Cap | 25.7 Million |
| Num Shares | 55 Million |
| EPS | -0.11 |
| Price-to-Earnings (P/E) Ratio | -4.17 |
| Price-to-Sales | 5.78 |
| Price-to-Book | 2.59 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.51 | ||||
| Resistance 3 (R3) | 0.51 | 0.50 | 0.50 | ||
| Resistance 2 (R2) | 0.50 | 0.49 | 0.50 | 0.50 | |
| Resistance 1 (R1) | 0.48 | 0.48 | 0.48 | 0.48 | 0.50 |
| Pivot Point | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
| Support 1 (S1) | 0.46 | 0.46 | 0.45 | 0.45 | 0.44 |
| Support 2 (S2) | 0.44 | 0.45 | 0.44 | 0.43 | |
| Support 3 (S3) | 0.43 | 0.44 | 0.43 | ||
| Support 4 (S4) | 0.42 |
